Developer docs
API playgroundTry for free, no card

Search company profiles

Dolphin Neurostim

Full company profile

uuid00241iv

Namestring
Dolphin Neurostim
Legal namestring
Center for Pain and Stress Research
Websiteurl
dolphinmps.com
Company typeenum
Private
Founded yearint
1989
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, United States
HQ citystring
Toronto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microcurrent stimulation therapy, pain management devices, medical device manufacturing, electrotherapy equipment, healthcare professional training
Industry3 codes
PRIMARYCRACAQAK
Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Microcurrent Pain Management Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Dolphin Neurostim Hardware Sales
TypeHardware Sales
Description

Sale of the Dolphin Neurostim device and kits. Products include Pain Management Kit ($424), Scar Release Kit ($749), various VNS combination kits, and upgrade packages. One-time hardware purchase with 1-year warranty and 30-day money-back guarantee.

dolphinmps.com
2Accessories and Consumables
TypeHardware Sales
Description

Sales of accessories including holsters ($25-$30), dual wrist straps ($25), extension probes ($25), deluxe carrying cases ($40), and electrode pads. Ongoing accessory purchases complement the device.

dolphinmps.com
3MPS Education and Training Courses
TypeProfessional Services
Description

Online and in-person certification courses for healthcare professionals. Courses include Intro to MPS Pain Therapy (12 CEs, $399), Scar Release Therapy (12 CEs, $499), Advanced Auricular Therapy (12 CEs, $499), and specialized courses like Brain Healing/Concussion protocols. Courses serve as both revenue stream and customer acquisition driver.

dolphinmps.com
4Educational Content and DVDs
TypeProfessional Services
Description

Sale of educational materials including DVDs and USB content such as 'Kinetic Chain Patterns And MPS Scar Therapy For Complicated Shoulder Conditions' ($60).

dolphinmps.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Pricing details10 tiers
1Dolphin Pain Management Kit - Entry-level professional device
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $424.00 - Includes carry case and 55-page protocol manual for basic pain management applications.

dolphinmps.com
2Dolphin Scar Release Kit - Advanced dual-unit kit for comprehensive therapy
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $749.00 - Includes two Dolphin units for bilateral/scar release treatments, carry case, and protocol manual.

dolphinmps.com
3Dolphin Pain Management + VNS Kit - Pain management with vagus nerve stimulation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $724.00 (was $824.00) - Includes VNS accessories for additional vagal stimulation therapy.

dolphinmps.com
4Dolphin Scar Release + VNS Kit - Full-featured professional kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $1049.00 (was $1149.00) - Includes two Dolphin units plus VNS accessories for comprehensive treatment.

dolphinmps.com
5Vagus Nerve Stim Kit - Accessory add-on for existing customers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $399.00 - Standalone VNS kit for existing Dolphin users to add vagus nerve stimulation capability.

dolphinmps.com
6Dolphin Single Unit Upgrade - Upgrade older model devices
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $250.00 - Trade-in program for older Dolphin model devices to newer version.

dolphinmps.com
7Dolphin Double Unit Upgrade - Dual-unit upgrade package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

USD $500.00 - Upgrade package for users needing two Dolphin units for Scar Release therapy.

dolphinmps.com
8MPS Pain Therapy Introductory Online Course
ModelUnit PricingBilling cadencePay-as-you-go
Notes

12 CE credits, $399.00 - Online certification course for healthcare professionals learning MPS pain therapy protocols.

dolphinmps.com
9MPS Scar Release Therapy Online Course
ModelUnit PricingBilling cadencePay-as-you-go
Notes

12 CE credits, $499.00 - Advanced certification course covering scar release techniques and protocols.

dolphinmps.com
10Advanced MPS Auricular Therapy Online Course
ModelUnit PricingBilling cadencePay-as-you-go
Notes

12 CE credits, $499.00 - Ear therapy certification covering anatomy, location and application of ear points.

dolphinmps.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dolphin Neurostim manufactures and sells FDA-cleared Class II medical devices that deliver Direct Current (DC) Microcurrent Point Stimulation (MPS) to acupuncture, trigger, and vagus nerve points for pain management, scar release, and nervous system regulation. The product line spans dedicated pain management and scar release kits, vagus nerve stimulation (VNS) kits, accessories, upgrade packages, and a portfolio of CE-accredited online certification courses for healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • 82% pain relief reported in published study (OGN Int Med 2019)
+14 more records
Product overview1 text field

Dolphin Neurostim offers a portfolio of medical devices and educational courses centered around Microcurrent Point Stimulation (MPS) therapy. The core product line consists of the Dolphin Neurostim device, available in several kit configurations: the Dolphin Pain Management Kit (USD $424), the Dolphin Scar Release Kit (USD $749), and combination kits with Vagus Nerve Stimulation (VNS) accessories. Upgrade packages are available for customers with older Dolphin models. The product portfolio also includes accessories such as holsters, wrist straps, extension probes, and carrying cases. Educational offerings include online and live courses for MPS Pain Therapy, Scar Release Therapy, Auricular Therapy, Concussion/Brain Healing, Sensory Balancing, and Pelvic Floor Therapy, with CEU credits available. The company has been in business for over 36 years, with the device FDA Cleared and Health Canada Licenced.

Product and service1 record
1Dolphin Pain Management Kit
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Acumed Medical, Ltd. serves as the US supplier for Dolphin Neurostim products. Contact information includes phone 1-800-567-7246 and email info@dolphinmps.com. Handles US distribution and customer support.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

DJO/Chattanooga is a major rehabilitation and pain management equipment manufacturer with professional-channel distribution. Both serve physiotherapists, chiropractors, and pain clinics, though DJO's portfolio spans far more modalities than MPS-specific microcurrent therapy.

TypeEmerging player
Description

Cala Health develops wearable transcutaneous afferent patterned stimulation (TAPS) therapy for essential tremor and is expanding into other indications. Both are emerging neuromodulation companies pursuing clinical evidence and prescription-adjacent positioning, though Cala focuses on tremor while Dolphin focuses on pain/scar/VNS.

3AxioBionics
TypeEmerging player
Description

AxioBionics develops wearable neurostimulation and electrical therapy devices for pain and muscle rehabilitation. Both operate in the electrotherapy category serving practitioners and patients, though AxioBionics focuses on functional electrical stimulation (FES) more than MPS.

4Omron Healthcare
TypeBroad incumbent
Description

Omron is a global incumbent in personal TENS/pain management devices with broad retail distribution (pharmacies, mass retail). Both sell FDA-cleared TENS-class devices for pain relief, but Omron competes at mass-market price points and scale rather than the clinical DC microcurrent niche.

TypeDirect peer
Description

iTENS manufactures and sells TENS devices directly to consumers for pain management, similar to Dolphin's OTC positioning. Both compete in the consumer-friendly transcutaneous electrotherapy category, though Dolphin differentiates on DC microcurrent vs. iTENS's standard TENS approach.

TypeDirect peer
Description

BioElectronics manufactures ActiPatch and RecoveryRx pulsed shortwave therapy devices for pain management and recovery. Both target the same OTC pain management consumer with FDA-cleared electrotherapy alternatives to drugs and traditional TENS.

TypeDirect peer
Description

electroCore markets gammaCore, a non-invasive vagus nerve stimulation device for headache and migraine. Both Dolphin (via its VNS accessory) and electroCore compete in non-invasive VNS for clinical and consumer use, with overlapping indications in headache/migraine pain management.

TypeBroad incumbent
Description

LivaNova (formerly Cyberonics) is the leading implantable vagus nerve stimulation company with extensive clinical evidence in epilepsy, depression, and heart failure. While Dolphin's VNS is non-invasive auricular stimulation, LivaNova represents the clinical gold standard and validates the VNS therapeutic area Dolphin is expanding into.

TypeDirect peer
Description

Avacen markets FDA-cleared thermal circulation enhancement devices for pain management, competing in the same non-pharmaceutical pain relief category as Dolphin. Both pursue OTC and professional channels with clinical evidence supporting non-invasive pain therapy.

TypeDirect peer
Description

NeuroMetrix markets wearable neurostimulation devices (e.g., Quell) for chronic pain. Both companies pursue prescription-adjacent, OTC-electrotherapy positioning for pain management and have similar regulatory pathways and clinical-evidence-driven marketing strategies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dolphin Neurostim

Microcurrent Pain Management Devicesdolphinmps.com

Dolphin Neurostim firmographics

Firmographics
Name
Dolphin Neurostim
Legal name
Center for Pain and Stress Research
Website
https://dolphinmps.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Dolphin Neurostim industry classification

Industry
Product category
Microcurrent Pain Management Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYCRACAQAK
Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Microcurrent stimulation therapy
  • Pain management devices
  • Medical device manufacturing
  • Electrotherapy equipment
  • Healthcare professional training

Where Dolphin Neurostim is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Dolphin Neurostim business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

  1. Dolphin Neurostim Hardware Sales: Sale of the Dolphin Neurostim device and kits. Products include Pain Management Kit ($424), Scar Release Kit ($749), various VNS combination kits, and upgrade packages. One-time hardware purchase with 1-year warranty and 30-day money-back guarantee.
  2. Accessories and Consumables: Sales of accessories including holsters ($25-$30), dual wrist straps ($25), extension probes ($25), deluxe carrying cases ($40), and electrode pads. Ongoing accessory purchases complement the device.
  3. MPS Education and Training Courses: Online and in-person certification courses for healthcare professionals. Courses include Intro to MPS Pain Therapy (12 CEs, $399), Scar Release Therapy (12 CEs, $499), Advanced Auricular Therapy (12 CEs, $499), and specialized courses like Brain Healing/Concussion protocols. Courses serve as both revenue stream and customer acquisition driver.
  4. Educational Content and DVDs: Sale of educational materials including DVDs and USB content such as 'Kinetic Chain Patterns And MPS Scar Therapy For Complicated Shoulder Conditions' ($60).

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDolphin Pain Management Kit - Entry-level professional device
Unit PricingPay-as-you-goDolphin Scar Release Kit - Advanced dual-unit kit for comprehensive therapy
Unit PricingPay-as-you-goDolphin Pain Management + VNS Kit - Pain management with vagus nerve stimulation
Unit PricingPay-as-you-goDolphin Scar Release + VNS Kit - Full-featured professional kit
Unit PricingPay-as-you-goVagus Nerve Stim Kit - Accessory add-on for existing customers
Unit PricingPay-as-you-goDolphin Single Unit Upgrade - Upgrade older model devices
Unit PricingPay-as-you-goDolphin Double Unit Upgrade - Dual-unit upgrade package
Unit PricingPay-as-you-goMPS Pain Therapy Introductory Online Course
Unit PricingPay-as-you-goMPS Scar Release Therapy Online Course
Unit PricingPay-as-you-goAdvanced MPS Auricular Therapy Online Course

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Dolphin Neurostim product offering

Product offering

Core offering

Dolphin Neurostim manufactures and sells FDA-cleared Class II medical devices that deliver Direct Current (DC) Microcurrent Point Stimulation (MPS) to acupuncture, trigger, and vagus nerve points for pain management, scar release, and nervous system regulation. The product line spans dedicated pain management and scar release kits, vagus nerve stimulation (VNS) kits, accessories, upgrade packages, and a portfolio of CE-accredited online certification courses for healthcare professionals.

Product overview

Dolphin Neurostim offers a portfolio of medical devices and educational courses centered around Microcurrent Point Stimulation (MPS) therapy. The core product line consists of the Dolphin Neurostim device, available in several kit configurations: the Dolphin Pain Management Kit (USD $424), the Dolphin Scar Release Kit (USD $749), and combination kits with Vagus Nerve Stimulation (VNS) accessories. Upgrade packages are available for customers with older Dolphin models. The product portfolio also includes accessories such as holsters, wrist straps, extension probes, and carrying cases. Educational offerings include online and live courses for MPS Pain Therapy, Scar Release Therapy, Auricular Therapy, Concussion/Brain Healing, Sensory Balancing, and Pelvic Floor Therapy, with CEU credits available. The company has been in business for over 36 years, with the device FDA Cleared and Health Canada Licenced.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dolphin Pain Management Kit

Quantifiable outcome

  • 82% pain relief reported in published study (OGN Int Med 2019)
  • +14 more outcomes

Companies that use Dolphin Neurostim

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Dolphin Neurostim technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Dolphin Neurostim partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Acumed Medical, Ltd.coreOthersAcumed Medical, Ltd. serves as the US supplier for Dolphin Neurostim products. Contact information includes phone 1-800-567-7246 and email info@dolphinmps.com. Handles US distribution and customer support.

Scale indicators6 records

Recent moves5 records

Dolphin Neurostim competitors and assessment

Company assessment

Broad incumbents

  • Chattanooga Group (DJO): DJO/Chattanooga is a major rehabilitation and pain management equipment manufacturer with professional-channel distribution. Both serve physiotherapists, chiropractors, and pain clinics, though DJO's portfolio spans far more modalities than MPS-specific microcurrent therapy.
  • Omron Healthcare: Omron is a global incumbent in personal TENS/pain management devices with broad retail distribution (pharmacies, mass retail). Both sell FDA-cleared TENS-class devices for pain relief, but Omron competes at mass-market price points and scale rather than the clinical DC microcurrent niche.
  • LivaNova: LivaNova (formerly Cyberonics) is the leading implantable vagus nerve stimulation company with extensive clinical evidence in epilepsy, depression, and heart failure. While Dolphin's VNS is non-invasive auricular stimulation, LivaNova represents the clinical gold standard and validates the VNS therapeutic area Dolphin is expanding into.

Emerging players

  • Cala Health: Cala Health develops wearable transcutaneous afferent patterned stimulation (TAPS) therapy for essential tremor and is expanding into other indications. Both are emerging neuromodulation companies pursuing clinical evidence and prescription-adjacent positioning, though Cala focuses on tremor while Dolphin focuses on pain/scar/VNS.
  • AxioBionics: AxioBionics develops wearable neurostimulation and electrical therapy devices for pain and muscle rehabilitation. Both operate in the electrotherapy category serving practitioners and patients, though AxioBionics focuses on functional electrical stimulation (FES) more than MPS.

Direct peers

  • iTENS: iTENS manufactures and sells TENS devices directly to consumers for pain management, similar to Dolphin's OTC positioning. Both compete in the consumer-friendly transcutaneous electrotherapy category, though Dolphin differentiates on DC microcurrent vs. iTENS's standard TENS approach.
  • BioElectronics Corporation: BioElectronics manufactures ActiPatch and RecoveryRx pulsed shortwave therapy devices for pain management and recovery. Both target the same OTC pain management consumer with FDA-cleared electrotherapy alternatives to drugs and traditional TENS.
  • electroCore: electroCore markets gammaCore, a non-invasive vagus nerve stimulation device for headache and migraine. Both Dolphin (via its VNS accessory) and electroCore compete in non-invasive VNS for clinical and consumer use, with overlapping indications in headache/migraine pain management.
  • Avacen Medical: Avacen markets FDA-cleared thermal circulation enhancement devices for pain management, competing in the same non-pharmaceutical pain relief category as Dolphin. Both pursue OTC and professional channels with clinical evidence supporting non-invasive pain therapy.
  • NeuroMetrix: NeuroMetrix markets wearable neurostimulation devices (e.g., Quell) for chronic pain. Both companies pursue prescription-adjacent, OTC-electrotherapy positioning for pain management and have similar regulatory pathways and clinical-evidence-driven marketing strategies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Dolphin Neurostim social profiles

Digital presence

Dolphin Neurostim compliance and trust

Trust signal

Compliance2 records

Dolphin Neurostim financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dolphin Neurostim leadership team

Management profile

Number of profiles

Profiles1 record

Dolphin Neurostim funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dolphin Neurostim M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dolphin Neurostim

What does Dolphin Neurostim do?

Dolphin Neurostim manufactures and sells FDA-cleared Class II medical devices that deliver Direct Current (DC) Microcurrent Point Stimulation (MPS) to acupuncture, trigger, and vagus nerve points for pain management, scar release, and nervous system regulation. The product line spans dedicated pain management and scar release kits, vagus nerve stimulation (VNS) kits, accessories, upgrade packages, and a portfolio of CE-accredited online certification courses for healthcare professionals.

Is Dolphin Neurostim a public or private company?

Dolphin Neurostim is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dolphin Neurostim founded?

Dolphin Neurostim was founded in 1989. It employs 1 to 10 people.

Where is Dolphin Neurostim based?

Dolphin Neurostim is headquartered in Toronto, United States, in the North America region.

How does Dolphin Neurostim make money?

Four revenue lines are on record. Dolphin Neurostim Hardware Sales are the primary driver. The others are accessories and Consumables, MPS Education and Training Courses and educational Content and DVDs.

Who are Dolphin Neurostim's main competitors?

Broad incumbents on record are Chattanooga Group (DJO), Omron Healthcare and LivaNova. Emerging players are Cala Health and AxioBionics. Direct peers are iTENS, BioElectronics Corporation, electroCore, Avacen Medical and NeuroMetrix.

Does Dolphin Neurostim have an API?

No public API is recorded for Dolphin Neurostim.

What industry is Dolphin Neurostim in?

Dolphin Neurostim's product category is Microcurrent Pain Management Devices. Its primary akta.pro industry code is CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices), with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireNew Study Shows Home-Based Microcurrent Therapy Reduces Pain, PTSD Symptoms, and Improves Sleep in Military VeteransA study published in the Journal of Complementary Medicine evaluated 35 U.S. and Canadian veterans who self-administered microcurrent point stimulation using the Dolphin Neurostim device at home, finding 52.2% pain reduction, 30% reduction in PTSD symptoms, and 39.5% increase in sleep duration after one year of use.PR NewswireNew Research Provides Breakthrough for Diabetes and Diabetic NeuropathyResearch published in Medical Acupuncture indicates that Microcurrent Point Stimulation (MPS) significantly reduces physical stress and improves the PTGVLFi marker associated with diabetes and diabetic neuropathy. The study utilized Dolphin Neurostim devices to apply an acupuncture protocol, resulting in a 27% reduction in stress and a 36% improvement in the key scientific marker after a single application. This non-invasive therapy offers potential clinical implications for managing glucose intolerance and microcirculation complications.PR NewswireMicrocurrent Applied by Point Stimulation (MPS): New Hope for Chronic Neuropathy Back Pain SufferersA case study conducted by the Center for Pain & Stress Research tested three electro-therapy treatments on a 57-year-old patient with chronic neuropathic back pain: placebo, AC TENS, and DC Microcurrent applied by Point Stimulation (MPS) using the Dolphin Neurostim device. The results showed that DC MPS applied to active acupuncture points provided complete relief from neuropathic pain by dramatically reducing cortisol and stress levels, while the other two treatments failed to reduce pain. The article suggests this technology has significant implications for the treatment of chronic neuropathic pain and warrants further research.